EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Combinatorial cancer therapy mediated by hydroxyapatite nanoparticles: a comprehensive review

Khadija Fatima, Iqra Fatima Khan, Sidra Fatima Khan, Tao Fu, Jing Wu

Medical Oncology · 08.07.2026 · 43 (8)

DOI: 10.1007/s12032-026-03325-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medical Oncology, online erschienen am 08.07.2026. Verfasst von Khadija Fatima und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'a…. Hauptthemen laut MEDLINE: Durapatite, Nanoparticles, Neoplasms. Die Arbeit nennt 149 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hydroxyapatite nanoparticles (HANPs) have emerged as versatile and biocompatible platforms in cancer nanomedicine, offering multifunctional roles in drug delivery, imaging, and combinatorial therapy. Their structural similarity to bone apatite, tunable surface chemistry, and ion substitution capability enable precise functionalization for targeted and sustained drug release. This review provides a comprehensive overview of HA-mediated combinatorial cancer therapies, emphasizing their role as drug carriers, photothermal agents, and immunomodulators. The integration of HANPs with chemotherapeutic drugs, immunotherapy, photothermal and photodynamic therapy, and trace-element doping has shown significant synergistic effects enhancing antitumor efficacy while minimizing systemic toxicity. Furthermore, HANPs have demonstrated promise as theranostic agents by combining therapeutic and diagnostic functions through multimodal imaging techniques, including MRI, fluorescence, and PET/SPECT. Collectively, these advances underscore HANPs as intelligent, biocompatible nanoplatforms capable of simultaneous diagnosis and therapy. Despite remarkable preclinical progress, future studies must address scalability, long-term biosafety, and clinical translation to realize their potential in precision oncology fully.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DurapatiteNanoparticlesNeoplasmsHumansAnimalsDrug Delivery SystemsCombined Modality TherapyAntineoplastic AgentsImmunotherapy

Stichwörter der Autor:innen

Combinatorial cancer therapyDrug deliveryHydroxyapatite nanoparticlesImmunotherapyNanomedicinePhotothermal therapyTheranostics

Substanzen

DurapatiteAntineoplastic Agents

Autor:innen und Institutionen

  • Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, 710049, China.
  • University of Mianwali, Mianwali, Pakistan.
  • Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, 710049, China. taofu@xjtu.edu.cn.
  • Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, 710049, China. jing_wu@xjtu.edu.cn.

Zitieren

APA

Fatima, K., Khan, I. F., Khan, S. F., Fu, T., & Wu, J. (2026). Combinatorial cancer therapy mediated by hydroxyapatite nanoparticles: a comprehensive review. Medical Oncology, 43(8). https://doi.org/10.1007/s12032-026-03325-3

Vancouver

Fatima K, Khan IF, Khan SF, Fu T, Wu J. Combinatorial cancer therapy mediated by hydroxyapatite nanoparticles: a comprehensive review. Medical Oncology. 2026;43(8). doi:10.1007/s12032-026-03325-3

BibTeX
@article{Fatima2026,
  author = {Fatima, Khadija and Khan, Iqra Fatima and Khan, Sidra Fatima and Fu, Tao and Wu, Jing},
  title = {Combinatorial cancer therapy mediated by hydroxyapatite nanoparticles: a comprehensive review},
  journal = {Medical Oncology},
  year = {2026},
  volume = {43},
  number = {8},
  doi = {10.1007/s12032-026-03325-3}
}
Kostenlos starten →